Origin and Establishment

Established in 1976 by J.W. Shay and colleagues, the MDA-MB-231 cell line was derived from a pleural effusion of a 51-year-old Caucasian woman with metastatic breast cancer. This cell line is categorized as a human breast adenocarcinoma and is notable for its lack of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, classifying it as a triple-negative breast cancer cell line.

Hera BioLabs

Key Characteristics

MDA-MB-231 cells exhibit several distinctive features that contribute to their prominence in research:

• Aggressiveness and Invasiveness: These cells are highly aggressive and invasive, mirroring the behavior of metastatic breast cancer. They possess a mesenchymal phenotype, characterized by high expression of the vimentin, a marker associated with increased motility and invasiveness.

  IIAR Journals

• Triple-Negative Status: The absence of ER, PR, and HER2 receptors makes MDA-MB-231 a representative model for TNBC, a subtype of breast cancer that is often more challenging to treat due to the lack of targeted hormonal therapies.

  AcceGen

• Mesenchymal Phenotype: The cells exhibit characteristics typical of mesenchymal cells, including a spindle-like morphology and the ability to undergo epithelial-mesenchymal transition (EMT), a process linked to cancer metastasis.

  IIAR Journals

Applications in Research

The MDA-MB-231 cell line serves as a versatile model in various research domains:

• Drug Development and Testing: Researchers utilize MDA-MB-231 cells to screen potential therapeutic agents, assess drug efficacy, and study mechanisms of drug resistance, particularly in the context of TNBC.

• Metastasis Studies: Due to their invasive nature, these cells are employed to investigate the molecular mechanisms underlying cancer metastasis, including cell migration, invasion, and interaction with the tumor microenvironment.

• Gene Expression Analysis: MDA-MB-231 cells are used to study gene expression profiles associated with aggressive breast cancer phenotypes, aiding in the identification of potential biomarkers and therapeutic targets.

• 3D Culture Models: The cell line is instrumental in developing three-dimensional (3D) culture systems, such as spheroids, to better mimic the in vivo tumor environment and study cell-cell and cell-matrix interactions.

  PMC

Culturing MDA-MB-231 Cells

Maintaining MDA-MB-231 cells requires adherence to specific culture conditions to ensure their viability and experimental reliability:

• Growth Medium: The cells are typically cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) to provide essential nutrients and growth factors.

• Incubation Conditions: Cultures are maintained at 37°C in a humidified atmosphere with 5% CO₂ to mimic physiological conditions.

• Subculturing: Regular passaging is necessary to prevent over-confluence. Cells are detached using trypsin-EDTA solution, resuspended in fresh medium, and seeded into new culture vessels.

  UCSC Genome Browser

• Cryopreservation: For long-term storage, cells are cryopreserved in a medium containing 10% dimethyl sulfoxide (DMSO) and stored in liquid nitrogen.

Advantages and Limitations

While MDA-MB-231 cells offer numerous advantages, researchers must also consider certain limitations:

• Advantages:

  • Reproducibility: As a well-characterized cell line, MDA-MB-231 provides consistent and reproducible results across studies.

  • Relevance to TNBC: The cell line's triple-negative status makes it particularly relevant for studying TNBC, a subtype lacking targeted therapies.

• Limitations:

  • Genetic Drift: Prolonged passaging can lead to genetic and phenotypic changes, potentially affecting experimental outcomes.

  • Lack of Tumor Heterogeneity: As a clonal cell line, MDA-MB-231 lacks the heterogeneity present in primary tumors, which may limit the extrapolation of findings to clinical settings.

Ethical Considerations

The use of human-derived cell lines like MDA-MB-231 necessitates ethical considerations, including informed consent from the donor and adherence to guidelines for the use of human biological materials in research.

Conclusion

The MDA-MB-231 cell line remains an indispensable resource in breast cancer research, offering valuable insights into the biology of triple-negative breast cancer and facilitating the development of potential therapeutic strategies. Its unique characteristics continue to make it a cornerstone in the ongoing battle against one of the most aggressive forms of breast cancer.

For researchers seeking high-quality MDA-MB-231 cells, Cytion provides well-characterized cell lines to support your scientific endeavors. Explore more about MDA-MB-231 cells and related products on Cytion's website.